Explore more publications!
Reunion Technology Digest
Got News to Share?

Reunion Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Technology Digest.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on November 7, 2025

From Immigrant Roots to Market Mastery: Elder Santis Expands Master Trader Corp’s Educational Programs to Empower the Next Generation of Structured Traders
November 7, 2025

From Immigrant Roots to Market Mastery: Elder Santis Expands Master Trader Corp’s Educational Programs to Empower the Next Generation of Structured Traders

Indeterminate GlobeNewswire
Protext Mobility, Inc. (OTC: TXTM) Announces Launch Phase of Its Next-Generation Investor Relations Suite and Corporate Website Modernization — Ushering in a New Era of Transparency, Innovation, and Shareholder Confidence
November 7, 2025

Protext Mobility, Inc. (OTC: TXTM) Announces Launch Phase of Its Next-Generation Investor Relations Suite and Corporate Website Modernization — Ushering in a New Era of Transparency, Innovation, and Shareholder Confidence

Indeterminate GlobeNewswire
ToAuto Launches Global Holiday Crafting Challenge After Viral 12M-View Candle Campaign
November 7, 2025

ToAuto Launches Global Holiday Crafting Challenge After Viral 12M-View Candle Campaign

Indeterminate GlobeNewswire
Julyana Free Zone Celebrates Milestone Partnership with Kaleris and ISFP for Smart Port Transformation
November 7, 2025

Julyana Free Zone Celebrates Milestone Partnership with Kaleris and ISFP for Smart Port Transformation

Indeterminate GlobeNewswire
OSE Immunotherapeutics Presents a Poster on OSE-Cytomask®, a Novel “Cis-Demasking” Cytokine Technology to Increase Therapeutic Index of Immunocytokines
November 7, 2025

OSE Immunotherapeutics Presents a Poster on OSE-Cytomask®, a Novel “Cis-Demasking” Cytokine Technology to Increase Therapeutic Index of Immunocytokines

Indeterminate GlobeNewswire
Présentation poster sur OSE-Cytomask®, une technologie innovante de « Cis-Démasquage » des cytokines visant à augmenter l’indice thérapeutique des immunocytokines
November 7, 2025

Présentation poster sur OSE-Cytomask®, une technologie innovante de « Cis-Démasquage » des cytokines visant à augmenter l’indice thérapeutique des immunocytokines

Indeterminate GlobeNewswire
4Thought Technologies CEO and EY Entrepreneur of the Year Award Nominee Richie Sater Transitions to Managing Partner Role at Sigil Intelligence Systems.
November 7, 2025

4Thought Technologies CEO and EY Entrepreneur of the Year Award Nominee Richie Sater Transitions to Managing Partner Role at Sigil Intelligence Systems.

Indeterminate GlobeNewswire
ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB)
November 7, 2025

ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB)

Indeterminate GlobeNewswire
SIXUNITED Showcases Its Full-Stack AI Ecosystem at the 2025 Intel® WW LOEM Summit
November 7, 2025

SIXUNITED Showcases Its Full-Stack AI Ecosystem at the 2025 Intel® WW LOEM Summit

Indeterminate GlobeNewswire
Roastrivc Launches Global Institutional Liquidity Integration Program to Build a Multi-Center Clearing Network
November 7, 2025

Roastrivc Launches Global Institutional Liquidity Integration Program to Build a Multi-Center Clearing Network

Indeterminate GlobeNewswire
Credit Blockchain To Launch Innovative Digital Asset Management Plans for Bitcoin, Ethereum, and Doge
November 7, 2025

Credit Blockchain To Launch Innovative Digital Asset Management Plans for Bitcoin, Ethereum, and Doge

Indeterminate GlobeNewswire
IP Strategy Issues Statement on Aria’s Successful Token Launch on the Story IP Blockchain
November 7, 2025

IP Strategy Issues Statement on Aria’s Successful Token Launch on the Story IP Blockchain

Indeterminate GlobeNewswire
red violet Named to TIME’s America’s Growth Leaders of 2026 List
November 7, 2025

red violet Named to TIME’s America’s Growth Leaders of 2026 List

Indeterminate GlobeNewswire
Jet.AI and Consensus Core Complete Second Milestone of Canadian Hyperscale Data Center Project
November 7, 2025

Jet.AI and Consensus Core Complete Second Milestone of Canadian Hyperscale Data Center Project

Indeterminate GlobeNewswire
Easy Environmental Solutions Begins Trading Under New Ticker Symbol “EZES”
November 7, 2025

Easy Environmental Solutions Begins Trading Under New Ticker Symbol “EZES”

Indeterminate GlobeNewswire
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
November 7, 2025

Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Indeterminate GlobeNewswire
Tizona Therapeutics Presents Clinical Translational Evidence of Dual Innate and Adaptive Immune Activation with TTX-080, a First-in-Class HLA-G Antagonist, in Patients with Advanced Solid Tumors at SITC 2025
November 7, 2025

Tizona Therapeutics Presents Clinical Translational Evidence of Dual Innate and Adaptive Immune Activation with TTX-080, a First-in-Class HLA-G Antagonist, in Patients with Advanced Solid Tumors at SITC 2025

Indeterminate GlobeNewswire
T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 7, 2025

T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Indeterminate GlobeNewswire
BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas
November 7, 2025

BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas

Indeterminate GlobeNewswire
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC
November 7, 2025

Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions